PsA Morbidity: Fatigue Ranked High Among Overall Patient Concerns
High fatigue levels are common among people with psoriatic arthritis, with patients raking it as second in importance after pain.
Spondyloarthritis
Multidisciplinary Partnerships in the Management of Uveitis in Patients With Rheumatic Disease
Uveitis may occur in patients with ankylosing spondylitis, juvenile rheumatoid arthritis, Behcet’s disease, and HLA B27-associated seronegative spondyloarthropathies. Prompt initiation of treatment may improve clinical outcomes, emphasizing the importance of collaboration between rheumatologists and ophthalmologists.
Calprotectin as a Reliable Surrogate Marker for Bowel Inflammation in SpA?
Fecal levels of calprotectin have been used as biomarkers of inflammatory bowel disease activity, and researchers speculated that its levels may be viable markers for bowel involvement in spondyloarthritis as well.
Diagnoses Associated With Inpatient Mortality in AS
Cervical spine fracture was identified as the leading cause of in-hospital mortality in patients with ankylosing spondylitis.
Similar Improvements in Etanercept-Treated PsA With or Without Methotrexate
Results of 2 clinical trials suggest that etanercept monotherapy and etanercept-methotrexate combination therapy may confer similar benefits in the treatment of psoriatic arthritis.
Management of Inflammatory Arthritis in Patients With Comorbid HIV Infection
Challenges of managing inflammatory arthritis in patients infected with HIV include difficulties in assessing disease activity and limited safety information for the use of immunosuppresive drugs in this patient population.
Post-Hoc Analysis of Ustekinumab Efficacy in PsA Patients With Spondylitis
Patients with comorbid active psoriatic arthritis and physician-diagnosed spondylitis treated with ustekinumab had improvements in peripheral arthritis, enthesitis, dactylitis, and physical function at 24 weeks.
Meta-Analysis Estimates Magnitude of Increased Cerebrovascular, Cardiovascular Morbidity in PsA
A meta-analysis suggests that psoriatic arthritis may be an independent risk factor for the development of cardiovascular disease.
Factors Influencing Rates of Adherence to Medications for Arthritis
The current research on adherence to interventions for arthritis has shown inconsistent impacts on disease outcomes.
Effects of Switching Patients With AS to the Infliximab Biosimilar CT-P13
Results were reported from an open-label, single-arm, multicenter extension study assessing the long-term efficacy and safety of multiple doses of the infliximab biosimilar CT-P13 in patients with ankylosing spondylitis.
- Loading...
Loading...
Loading... 
Loading...